LSU LCMC Health Cancer Center | Strategic Alliance Partners

home / sap-partner / cancer-centers / lsu-lcmc-health-cancer-center

Latest from LSU LCMC Health Cancer Center

Giulia Monticone, PhD

LSU Health New Orleans Announces Groundbreaking Research on Remdesivir’s Novel Immunological Effects

August 5th 2024

LSU Health New Orleans is proud to announce the publication of a groundbreaking study led by Giulia Monticone PhD in the prestigious journal EMBO Reports.

Augusto Ochoa, principal investigator, Gulf South Clinical Trials Network, deputy director, LSU LCMC Health Cancer Center

Gulf South Clinical Trials Network Named a Spoke in the ARPA-H Customer Experience Catalyst Hub

April 11th 2024

The Gulf South Clinical Trials Network has been named a spoke in the ARPA-H Customer Experience Hub, one of 3 regional hubs that comprise ARPANET-H.

Michael Hagensee, MD, PhD, Louisiana State University Health, New Orleans School of Medicine

Dr Hagensee on Strategies For Cervical Cancer Prevention

February 14th 2024

Michael Hagensee, MD, PhD, discusses strategies for cervical cancer prevention and ongoing research investigating barriers to cervical cancer treatment.

OncLive Teams Up With LSU's Stanley S. Scott Cancer Center to Publicize Center's Innovative Cancer Research and Community-Based Programs

OncLive Teams Up With LSU's Stanley S. Scott Cancer Center to Publicize Center's Innovative Cancer Research and Community-Based Programs

November 12th 2015

Strategic Alliance Partnership will strengthen outreach to cancer patients.

Novel Agents Signal Progress in the Management of Platinum-Resistant Ovarian Cancer

Novel Agents Signal Progress in the Management of Platinum-Resistant Ovarian Cancer

October 15th 2015

The evaluation of noncytotoxic agents for the treatment of epithelial ovarian cancer has produced encouraging findings in recent months, which has led to the approval of new agents with novel mechanisms of action and continuing studies into many more potential therapies.